Back to Journals » Vascular Health and Risk Management » Volume 12 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/2/cope/thumb_100_1000_100.jpg)
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1524)
- Volume 20, 2024 (28)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 12, 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prevalence of cardiovascular risk factors among workers at a private tertiary center in Angola
Paquissi FC, Manuel V, Manuel A, Mateus GL, David B, Béu G, Castela A
Vascular Health and Risk Management 2016, 12:497-503
Published Date: 14 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Results of a venous thromboembolism prophylaxis program for hospitalized patients
Cardoso LF, Krokoscz DV, Paiva EF, Furtado IS, Mattar Jr J, de Souza e Sá MM, de Lira AC
Vascular Health and Risk Management 2016, 12:491-496
Published Date: 12 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
Benes LB, Bassi NS, Davidson MH
Vascular Health and Risk Management 2016, 12:481-490
Published Date: 12 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Platelet count and platelet indices in women with preeclampsia
AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I
Vascular Health and Risk Management 2016, 12:477-480
Published Date: 21 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
Schellings DAAM, Adiyaman A, Dambrink JH, Gosselink ATM, Kedhi E, Roolvink V, Ottervanger JP, van't Hof AWJ
Vascular Health and Risk Management 2016, 12:471-476
Published Date: 21 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Advances in the management of heart failure: the role of ivabradine
Müller-Werdan U, Stöckl G, Werdan K
Vascular Health and Risk Management 2016, 12:453-470
Published Date: 17 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
Antza C, Stabouli S, Kotsis V
Vascular Health and Risk Management 2016, 12:443-451
Published Date: 15 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A stress-related explanation to the increased blood pressure and its course following ischemic stroke
Kvistad CE, Oygarden H, Logallo N, Thomassen L, Waje-Andreassen U, Moen G, Naess H
Vascular Health and Risk Management 2016, 12:435-442
Published Date: 11 November 2016
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/8ZZdEBYCiSM/1.jpg)
Gupta S
Vascular Health and Risk Management 2016, 12:421-433
Published Date: 10 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus
Derosa G, Maffioli P
Vascular Health and Risk Management 2016, 12:415-419
Published Date: 9 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S
Vascular Health and Risk Management 2016, 12:407-413
Published Date: 27 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure
Reed JW
Vascular Health and Risk Management 2016, 12:393-405
Published Date: 27 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
International normalized ratio self-testing and self-management: improving patient outcomes
Pozzi M, Mitchell J, Henaine AM, Hanna N, Safi O, Henaine R
Vascular Health and Risk Management 2016, 12:387-392
Published Date: 12 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Carbohydrate composition of circulating multiple-modified low-density lipoprotein
Zakiev ER, Sobenin IA, Sukhorukov VN, Myasoedova VA, Ivanova EA, Orekhov AN
Vascular Health and Risk Management 2016, 12:379-385
Published Date: 14 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial
Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS
Vascular Health and Risk Management 2016, 12:371-378
Published Date: 26 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Overview of guidelines for the management of dyslipidemia: EU perspectives
Giner-Galvañ V, Esteban-Giner MJ, Pallarés-Carratalá V
Vascular Health and Risk Management 2016, 12:357-369
Published Date: 6 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease
Herten M, Torsello GB, Schönefeld E, Stahlhoff S
Vascular Health and Risk Management 2016, 12:341-356
Published Date: 29 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Blood pressure and fasting lipid changes after 24 weeks’ treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naïve patients with type 2 diabetes mellitus
Evans M, Schweizer A, Foley JE
Vascular Health and Risk Management 2016, 12:337-340
Published Date: 18 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk impact of edoxaban in the management of stroke and venous thromboembolism
Hurst KV, O’Callaghan JM, Handa A
Vascular Health and Risk Management 2016, 12:329-335
Published Date: 11 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Predictors of high central blood pressure in young with isolated systolic hypertension
Radchenko GD, Torbas OO, Sirenko YM
Vascular Health and Risk Management 2016, 12:321-328
Published Date: 2 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of nitroglycerin administration on cardio-ankle vascular index
Shimizu K, Yamamoto T, Takahashi M, Sato S, Noike H, Shirai K
Vascular Health and Risk Management 2016, 12:313-319
Published Date: 3 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method
![](cr_data/cache/submission_images/s106000/106534/01_apr_2016_figure1_200_200_90.jpg)
Špan M, Geršak G, Millasseau SC, Meža M, Košir A
Vascular Health and Risk Management 2016, 12:305-311
Published Date: 29 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Biomarkers and the prediction of atrial fibrillation: state of the art
O’Neal WT, Venkatesh S, Broughton ST, Griffin WF, Soliman EZ
Vascular Health and Risk Management 2016, 12:297-303
Published Date: 18 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Matrix metalloproteinases in exercise and obesity
Jaoude J, Koh Y
Vascular Health and Risk Management 2016, 12:287-295
Published Date: 14 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Association between perceived lifetime risk of cardiovascular disease and calculated risk in a male population in Brazil
de Lima Jr MM, da Silva GR, Jansem Filho SS, Granja F
Vascular Health and Risk Management 2016, 12:279-286
Published Date: 22 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Noninvasive FFR derived from coronary CT angiography in the management of coronary artery disease: technology and clinical update
Nakanishi R, Budoff MJ
Vascular Health and Risk Management 2016, 12:269-278
Published Date: 22 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar
Cheng JWM
Vascular Health and Risk Management 2016, 12:263-268
Published Date: 14 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study
Haider A, Yassin A, Haider KS, Doros G, Saad F, Rosano GM
Vascular Health and Risk Management 2016, 12:251-261
Published Date: 14 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
Gurgle HE, White K, McAdam-Marx C
Vascular Health and Risk Management 2016, 12:239-249
Published Date: 4 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Elevated risk of venous thromboembolic events in patients with inflammatory myopathies
Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M
Vascular Health and Risk Management 2016, 12:233-238
Published Date: 3 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk factors for amputation in extremities vascular injuries in Saudi Arabia
Al Wahbi A, Aldakhil S, Al Turki S, El Kayali A, Al Kohlani H, Al Showmer A
Vascular Health and Risk Management 2016, 12:229-232
Published Date: 24 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease
Christiansen MK, Jensen JM, Brøndberg AK, Bøtker HE, Jensen HK
Vascular Health and Risk Management 2016, 12:219-227
Published Date: 25 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study
Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AGG
Vascular Health and Risk Management 2016, 12:209-218
Published Date: 18 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date
Barkat M, Torella F, Antoniou GA
Vascular Health and Risk Management 2016, 12:199-208
Published Date: 12 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
Blom DJ, Dent R, Castro RC, Toth PP
Vascular Health and Risk Management 2016, 12:185-197
Published Date: 9 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Toth PP
Vascular Health and Risk Management 2016, 12:171-183
Published Date: 6 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
Henry CA, Lyon RA, Ling H
Vascular Health and Risk Management 2016, 12:163-169
Published Date: 19 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of intracerebral hemorrhage – use of statins
Van Matre ET, Sherman DS, Kiser TH
Vascular Health and Risk Management 2016, 12:153-161
Published Date: 18 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry
Goldstein P, Grieco N, Ince H, Danchin N, Ramos Y, Goedicke J, Clemmensen P
Vascular Health and Risk Management 2016, 12:143-151
Published Date: 19 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeting heart failure with preserved ejection fraction: current status and future prospects
Kanwar M, Walter C, Clarke M, Patarroyo-Aponte M
Vascular Health and Risk Management 2016, 12:129-141
Published Date: 15 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Endovascular revascularization for aortoiliac atherosclerotic disease
Aggarwal V, Waldo SW, Armstrong EJ
Vascular Health and Risk Management 2016, 12:117-127
Published Date: 29 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cognitive impairment and stroke in elderly patients
Lo Coco D, Lopez G, Corrao S
Vascular Health and Risk Management 2016, 12:105-116
Published Date: 24 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Maeder MT, Schoch OD, Rickli H
Vascular Health and Risk Management 2016, 12:85-103
Published Date: 21 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prevalence and correlates of coronary heart disease: first population-based study in Lebanon
Zeidan RK, Farah R, Chahine MN, Asmar R, Hosseini H, Salameh P, Pathak A
Vascular Health and Risk Management 2016, 12:75-84
Published Date: 17 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Atrial fibrillation and silent stroke: links, risks, and challenges
![](cr_data/cache/submission_images/s81000/81807/id81807_fig2_200_200_90.jpg)
Hahne K, Mönnig G, Samol A
Vascular Health and Risk Management 2016, 12:65-74
Published Date: 7 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Type II endoleaks: challenges and solutions
Brown A, Saggu GK, Bown MJ, Sayers RD, Sidloff DA
Vascular Health and Risk Management 2016, 12:53-63
Published Date: 2 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Edoxaban in venous thromboembolism and stroke prevention: an appraisal
Proietti M, Lip GYH
Vascular Health and Risk Management 2016, 12:45-51
Published Date: 29 February 2016
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/q9YyRNlgNpo/1.jpg)
Hu TY, Vaidya VR, Asirvatham SJ
Vascular Health and Risk Management 2016, 12:35-44
Published Date: 17 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
Toth PP
Vascular Health and Risk Management 2016, 12:23-34
Published Date: 10 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The cost of inpatient death associated with acute coronary syndrome
Page II RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV
Vascular Health and Risk Management 2016, 12:13-21
Published Date: 3 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?
Foley JE, Bhosekar V, Kawamori R
Vascular Health and Risk Management 2016, 12:9-12
Published Date: 21 January 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical evaluation of the MitraClip system in the management of mitral regurgitation
Deuschl F, Schofer N, Lubos E, Blankenberg S, Schäfer U
Vascular Health and Risk Management 2016, 12:1-8
Published Date: 11 January 2016